Previous studies of patients with cervical cancer have described alterations in T cell and NK cell populations [13], suppression of NK cell activity by CD4+ regulatory T cells [14], and reduced numbers of CD4+ T cells and NK cells in the neoplastic cervix [15]. The gene discussed is CD4; the disease is cervical cancer.